STILBENE DERIVATIVES AS ANTICANCER AGENTS - Patent 0641301

(19)

(11)

EP 0 641 301 A1

(12)

(43)	Date of publication:
	08.03.1995 Bulletin 1995/10

(21)	Application number: 93914032.0

(22)	Date of filing: 20.05.1993

(51)

International Patent Classification (IPC):

C07C 43/ 205^{( . )}
C07C 43/ 225^{( . )}
C07C 45/ 46^{( . )}
C07C 47/ 575^{( . )}
C07C 49/ 84^{( . )}
C07C 65/ 21^{( . )}
C07C 69/ 157^{( . )}
C07C 205/ 35^{( . )}
C07C 217/ 58^{( . )}
C07C 217/ 84^{( . )}
C07C 233/ 25^{( . )}
C07C 235/ 56^{( . )}
C07C 255/ 37^{( . )}
C07C 323/ 36^{( . )}
C07D 217/ 20^{( . )}
C07F 7/ 18^{( . )}

C07C 43/ 215^{( . )}
C07C 43/ 23^{( . )}
C07C 45/ 71^{( . )}
C07C 49/ 755^{( . )}
C07C 59/ 64^{( . )}
C07C 69/ 017^{( . )}
C07C 69/ 708^{( . )}
C07C 217/ 18^{( . )}
C07C 217/ 80^{( . )}
C07C 219/ 10^{( . )}
C07C 235/ 34^{( . )}
C07C 251/ 16^{( . )}
C07C 323/ 18^{( . )}
C07D 213/ 30^{( . )}
C07D 455/ 00^{( . )}

(86)	International application number:
	PCT/US1993/004807

(87)	International publication number:
	WO 1993/023357 (25.11.1993 Gazette 1993/28)

(84)	Designated Contracting States:
	AT BE CH DE ES FR GB IE IT LI

(30)

Priority:

21.05.1992 US 19920887725

(71)	Applicant: Research Corporation Technologies, Inc.
	Tucson Arizona 85711-3335 (US)

(72)	Inventors:
	CUSHMAN, Mark, S. West Lafayette, IN 47906 (US) HAMEL, Ernest Bethesda, MD 20892 (US)

(74)	Representative: Schmidt-Evers, Jürgen, Dipl.-Ing.
	Patentanwälte Mitscherlich & Partner Postfach 33 06 09 D-80066 München D-80066 München (DE)

(54)	STILBENE DERIVATIVES AS ANTICANCER AGENTS